It found that the drug flavopiridol (DB03496 in column I row 3 of Figure 2b), which treats a number of cancers including esophageal, lung, liver, and lymphoid leukemia, could be used to treat patients with mutations in BRCA1. The gene discussed is BRCA1; the disease is cancer.